↓ Skip to main content

Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials

Overview of attention for article published in BMC Cancer, August 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

policy
2 policy sources
patent
1 patent

Citations

dimensions_citation
312 Dimensions

Readers on

mendeley
217 Mendeley
Title
Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials
Published in
BMC Cancer, August 2007
DOI 10.1186/1471-2407-7-153
Pubmed ID
Authors

Gustavo A Viani, Sergio L Afonso, Eduardo J Stefano, Ligia I De Fendi, Francisco V Soares

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 217 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 3 1%
United Kingdom 2 <1%
Korea, Republic of 2 <1%
Germany 1 <1%
Austria 1 <1%
Sudan 1 <1%
Portugal 1 <1%
Canada 1 <1%
Colombia 1 <1%
Other 2 <1%
Unknown 202 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 40 18%
Student > Ph. D. Student 31 14%
Student > Bachelor 27 12%
Student > Master 25 12%
Student > Postgraduate 19 9%
Other 44 20%
Unknown 31 14%
Readers by discipline Count As %
Medicine and Dentistry 101 47%
Agricultural and Biological Sciences 26 12%
Biochemistry, Genetics and Molecular Biology 12 6%
Pharmacology, Toxicology and Pharmaceutical Science 11 5%
Computer Science 5 2%
Other 22 10%
Unknown 40 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 October 2023.
All research outputs
#3,652,021
of 24,682,395 outputs
Outputs from BMC Cancer
#891
of 8,755 outputs
Outputs of similar age
#8,656
of 71,675 outputs
Outputs of similar age from BMC Cancer
#1
of 20 outputs
Altmetric has tracked 24,682,395 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,755 research outputs from this source. They receive a mean Attention Score of 4.6. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 71,675 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.